Teopranitol

This classification denotes a vasodilating agent with the molecular formula C16H22N6O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 631R1KON85, chemically known as 1,4:3,6-dianhydro-2-deoxy-2-((3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurin-7-yl)propyl)amino)-l-iditol 5-nitrate but generally known as teopranitol, which bears US NIH Compound Identifier 3034007. European Medicines Agency schedules Teopranitol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10902MIG. The term TEOPRANITOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). TEOPRANITOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule teopranitol under HS 29395900 and SITC 54145. As of Q4 2014, TEOPRANITOL remains the US FDA Preferred Term for this commodity. Teopranitol bears US NLM identifiers UMLS ID C0076104 and NCI Concept Code C66586. SMILES: O1C2C(OCC2O[N](=O)O)C(NCCCn2c3c(n(c(=O)n(c3=O)C)C)nc2)C1.